Virologic response in patients with chronic hepatitis C after treatment with interferon 2b alone or in combination with ribavirin.

被引：0
|
作者：
Futuh, ARA
Solayman, AEM
El Hendawy, SM
El Hadad, SM
Omar, MM
Kamel, MM
机构：
[1] Mansoura Int Hosp, Mansoura, Egypt
[2] Asuit Univ, Asuit, Egypt
[3] Univ Mansoura, Mansoura, Egypt
[4] Ein Shams Univ, Cairo, Egypt
[5] Theodor Bilharse Res Inst, Cairo, Egypt
[6] Ein Shams Univ, Cairo, Egypt
来源：
HEPATOLOGY | 2002年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1706
引用
收藏
页码：589A / 589A
页数：1
相关论文
共 50 条
  • [21] Continuous interferon-α2b infusion in combination with ribavirin for chronic hepatitis C in treatment-experienced patients
    Roomer, Robert
    Bergmann, Jilling F.
    Boonstra, Andre
    Hansen, Bettina E.
    Haagmans, Bart L.
    Kwadijk-de Gijsel, Sonja
    van Vuuren, Anneke J.
    de Knegt, Robert J.
    Janssen, Harry L. A.
    ANTIVIRAL THERAPY, 2012, 17 (03) : 509 - 517
  • [22] Virologic response to treatment with Pegylated Interferon alfa-2b and Ribavirin for chronic hepatitis C in children
    Pawlowska, Malgorzata
    Pilarczyk, Malgorzata
    Halota, Waldemar
    MEDICAL SCIENCE MONITOR, 2010, 16 (12): : CR616 - CR621
  • [23] Re-treatment virologic response in chronic hepatitis C virologic non-responders (NR) and responder-relapsers (NR) to interferon (IFN) monotherapy:: IFN α-2b induction followed by combination ribavirin/interferon α-2b vs combination ribavirin/interferon α-2b (780 MIU/52 weeks rebetron therapy).
    Pimstone, NR
    Canio, JB
    Chiang, MH
    Kokosinski, J
    Powell, JS
    Saicheur, T
    Sheykhzadeh, PI
    Yu, AS
    GASTROENTEROLOGY, 2001, 120 (05) : A568 - A568
  • [24] Consensus interferon in combination with ribavirin for hepatitis C patients with nonresponse or relapse to interferon alpha and ribavirin.
    Buggisch, P
    Hinrichsen, H
    Hueppe, D
    Reiser, M
    Kueppers, H
    Wursthorn, K
    Sterneck, M
    HEPATOLOGY, 2001, 34 (04) : 590A - 590A
  • [25] Interferon alfacon-1 and ribavirin versus interferon α-2b and ribavirin in the treatment of chronic hepatitis C
    Sjogren, MH
    Sjogren, R
    Holtzmuller, K
    Winston, B
    Butterfield, B
    Drake, S
    Watts, A
    Howard, R
    Smith, M
    DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (04) : 727 - 732
  • [26] Interferon Alfacon-1 and Ribavirin Versus Interferon α-2b and Ribavirin in the Treatment of Chronic Hepatitis C
    Maria H. Sjogren
    Robert Sjogren
    Kent Holtzmuller
    Bradley Winston
    Betty Butterfield
    Stanley Drake
    Amber Watts
    Robin Howard
    Milton Smith
    Digestive Diseases and Sciences, 2005, 50 : 727 - 732
  • [27] Interferon alfa 2b and ribavirin combination therapy for patients with chronic viral hepatitis C failing interferon therapy
    Galica, M
    Alhajjar, B
    Salen, G
    Dyrszka, H
    Sanghavi, B
    Eskreis, D
    HEPATOLOGY, 1998, 28 (04) : 709A - 709A
  • [28] Interferon alone or in combination with ribavirin for the treatment of chronic hepatitis C genotype IV
    Shiha, G
    Salem, S
    JOURNAL OF HEPATOLOGY, 2002, 36 : 129 - 129
  • [29] Treatment of chronic hepatitis C virus infection with α-interferon alone or in combination with ribavirin
    Marra, F
    Yoshida, EM
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1999, 8 (09) : 429 - 438
  • [30] The effect of induction pegylated interferon alfa 2b and ribavirin on early virologic response in genotype 1 chronic hepatitis C
    Lawitz, EJ
    Harrison, SA
    Cantu, NS
    Davis, M
    Perkel, M
    Vemuru, R
    Nguyen, T
    Kadakia, S
    Ganeshappa, KP
    Diamond, K
    Matossian, H
    Box, TD
    Ghandour, E
    GASTROENTEROLOGY, 2004, 126 (04) : A723 - A723
12345